ALS/MND treatment
Expected improvements in patients after our stem cell therapy for ALS
Stable and positive clinical effects after ALS treatment generally lasts for 4-6 months.
-
Decrease in weakness
-
Mood and appetite improvement
-
Decrease in fasciculations (twitching) and spasticity (muscle tightening)
-
Improvement in swallowing and speaking
-
Decrease in muscular rigidity, normalization of reflexes
-
Decrease in fasciculation zones
Amyotrophic Lateral Sclerosis (ALS) Stem Cell treatment at CellStemClinic
Amyotrophic lateral sclerosis (ALS) also known as motor neuron disease (MND) and Lou Gehrig’s disease, is a rare condition characterized by the degeneration of nerve cells that control voluntary muscles. The disease leads to gradually worsening symptoms that include muscle weakness, twitching, and stiffness. As more of these nerve cells, or motor neurons, are lost: muscles decrease in size and continue to weaken, eventually resulting in problems with speaking, swallowing, and breathing.
About treatment
CellStemClinic has experience in treating ALS using stem cells.
CellStemClinic’s ALS therapy opens new possibilities in treating this disease, potentially resulting in significant improvement of the patient’s motor activity with mental and emotional improvements.
Overall health and quality of life is generally much higher after stem cell therapy. Numerous research works and personal experience of ALS patients treated has proven this treatment to be absolutely safe for those living with ALS.
Currently, this therapy is considered the most modern and effective treatment method for ALS.
We offer 2 treatment programs for ALS patients.
-
2-day treatment with intravenous and subcutaneous use of stem cells: developed for patients with mild and moderate-to-severe ALS disease.
3-day treatment with both intravenous, subcutaneous and intrathecal injections: specially developed for the patients with moderate-to-severe ALS disease. This program is designed to increase the effectiveness of therapy among our patients who have more advanced conditions and greater impairment of central nervous system damage
Stem cell treatment for ALS (amyotrophic lateral sclerosis) is a therapy capable of curing or reversing the course of the disease; currently, clinical trials are actively investigating therapies aimed at slowing the progression of the disease and protecting motor neurons.
Research and experimental protocols primarily use mesenchymal stem cells (MSCs), which are usually harvested from the patient’s own fat or umbilical cord tissue.
Rather than directly growing or replacing damaged motor neurons—which is an incredibly complex process—the fundamental mechanism underlying these experimental therapies focuses on:
-
Neuroprotection: the release of natural proteins and growth factors that protect surviving motor neurons from stress and delay cell death.
-
Immune regulation: suppression of the destructive inflammation that occurs around nerve tissues in the brain and spinal cord.
-
Microenvironment repair: promotion of an environment more conducive to communication between nerves and muscles.
After treatment, our protocol requires patients to complete weekly reports to assess their progress in the following weeks. These reports will be forwarded to our specialists for further evaluation.
CellStemClinic Therapy
ALS/MND treatment
;
